How to prevent steroid induced osteoporosis

Annals of the Rheumatic Diseases

Volumn 64, Issue 2, 2005, Pages 176-178

  Sambrook, P N ^a  

^a Vascular Biology Laboratory   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; ALFACALCIDOL; BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; CALCITRIOL; CALCIUM; PAMIDRONIC ACID; PARATHYROID HORMONE; PREDNISONE; RISEDRONIC ACID; STEROID; TESTOSTERONE; VITAMIN D;

CLINICAL TRIAL; CORTICOSTEROID THERAPY; DRUG INDUCED DISEASE; HORMONAL THERAPY; HUMAN; OSTEOLYSIS; OSTEOPOROSIS; PRIORITY JOURNAL; REVIEW;

CALCIUM; DIPHOSPHONATES; GLUCOCORTICOIDS; HUMANS; OSTEOPOROSIS; VITAMIN D;

EID: 13244288707     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2003.018556     Document Type: Review

References (15)

1. Anonymous. Recommendations for the prevention and treatment of glucocorticoid induced osteoporosis, 2001 update. Arthritis Rheum 2001;44:1496-503.
2. Eastell R, Reid DM, Compston J, Cooper C, Fogelman I, Francis RM, et al. A UK consensus group on management of glucocorticoid induced osteoporosis: an update. J Intern Med 1998;244:271-92.
3. Anonymous. Guidelines on the prevention and treatment of glucocorticoid induced osteoporosis by the Bone and Tooth Society, National Osteoporosis Society and Royal College of Physicians. www.rcplondon.ac.uk/pubs/books/ glucocorticoid/index.asp (accessed 23 November 2004).
4. Selby PL, Halsey JP, Adams KRH, Klimiuk P, Knight SM, Pai B, et al. Corticosteroids do not alter the threshold for vertebral fractures. J Bone Miner Res 2000;15:952-6.
5. Van Staa TP, Laan RF, Barton IP, Cohen S, Reid DM, Cooper C. Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoids therapy. Arthritis Rheum 2003;48:3224-9.
6. Van Staa TP, Leufkens HGM, Abenhaim L, Zhang B, Cooper C. Use of oral glucocorticoids and risk of fractures. J Bone Miner Res 2000;15:993-1000.
7. Amin S, Lavalley MP, Simms RW, Felson DT. The comparative efficacy of drug therapies used for the management of corticosteroid induced osteoporosis: a meta regression. J Bone Miner Res 2002;17:1512-26.
8. Saag KG, Emkey R, Schnitzer TJ, Brown JP, Hawkins F, Goemaere S, et al. Alendronate for the prevention and treatment of glucocorticoid induced osteoporosis. N Engl J Med 1998;339:292-9.
9. Wallach S, Cohen S, Reid DM, Hughes RA, Hosking DJ, Laan RF, et al. Effects of risedronate treatment on bone density and vertebral fracture in patients on corticosteroid therapy. Calcif Tissue Inter 2000;67:277-85.
10. Adachi J, Bensen W, Bianchi F, Cividino A, Pillersdorf S, Sebaldt RJ, et al. Vitamin D and calcium in the prevention of corticosteroid-induced osteoporosis: a three year follow up study. J Rheumatol 1996;23:995-1000.
11. Buckley LM, Leib ES, Cartularo KS, Vacek PM, Cooper SM. Calcium and vitamin D3 supplementation prevents bone loss in the spine secondary to low dose corticosteroids in patients with rheumatoid arthritis. Ann Intern Med 1996;125:961-8.
12. Richy F, Ethgen O, Bruyere O, Reginster JY. Efficacy of alphacalcidol and calcitriol in primary and corticosteroid induced osteoporosis: a meta-analysis of their effects on bone density and fracture rate. Osteoporos Int 2004;15:301-10.
13. Sambrook PN, Kotowicz M, Nash P, Styles CB, Naganathan V, Henderson-Briffa KN, et al. Prevention and treatment of glucocorticoid induced osteoporosis: a comparison of calcitriol, vitamin D plus calcium and alendronate plus calcium. J Bone Miner Res 2003;18:919-24.
14. Reid IR, Wattie DJ, Evans MC, Stapletan JP. Testosterone therapy in glucocorticoid-treated men. Arch Int Med 1996;156:1173-7.
15. Lane NE, Sanchez S, Modin GW, Genant HK, Pierini E, Arnaud CD. Parathyroid hormone treatment can reverse corticosteroid-induced osteoporosis. J Clin Invest 1998;102:1627-33.